PROCEPT BioRobotics prices Nasdaq IPO
PROCEPT BioRobotics priced its upsized initial public offering and expected its shares to begin trading on Nasdaq under the PRCT ticker.
Evidence notes
- PROCEPT expected its common stock to begin trading on the Nasdaq Global Market on September 15, 2021.
- The IPO was priced at $25.00 per share.
- The company offered all shares in the upsized offering.
Company context
PROCEPT BioRobotics develops surgical robotic systems for Aquablation therapy, including image-guided robotic waterjet treatment for benign prostatic hyperplasia.